VP, Global Head Infection Prevention

Working Location: MASSACHUSETTS, WESTBOROUGH; District Columbia, Washington; Illinois, Chicago; PENNSYLVANIA, CENTER VALLEY 

 Workplace Flexibility: Field

Are you looking for a company that cares about people’s lives and health, including yours? Let’s inspire healthier lives, together.

 

Olympus, a leading medical technology company, has focused on making people’s lives better for over 100 years.

Our Purpose is to make people’s lives healthier, safer, and more fulfilling.

Job Description

The Infection Prevention Leader (IPL) is an experienced professional possessing deep experiential knowledge spanning all aspects of Infection Prevention (IP) and is responsible for providing holistic leadership for all IP functions across the product lifecycle to ensure that patient safety is a top priority. Serving as a single point of accountability for the design, execution, monitoring, delivery, and reporting of all IP activities for Olympus, the IPL will synergize independent successes of the Infection Prevention Center of Excellence (IPCOE) and Infection Prevention & Control (IPC). Fundamental competencies for this role include: 1.) Infection Prevention disease state, procedural, clinical, and technological market knowledge & experience, 2.) Comprehensive mastery of clinical infection prevention & control proficiencies (e.g., infection surveillance team, infection control committee, microbiological liaison, data analytics, epidemiological investigative principles, medical device/technology product evaluation, performance improvement, corrective action preventive action, root cause analysis, and risk management activities), from ideation to obsolescence across the product lifecycle, 3.) Capabilities in clinical integration of current and future infection prevention diagnostic/therapeutic devices & technologies to improve equitable access to care while delivering meaningful clinical and economic outcomes.  

 

The IPL will take charge of a highly matrixed environment to architect Olympus’ infection prevention global strategy encompassing all therapeutic areas and IP activities from an operational perspective. Matrixed relationships within Olympus will include colleagues from Quality Assurance, Regulatory Affairs, IP R&D teams, and the Infection Prevention Business Unit. The IPL will contribute decisively to new product development, design controls, risk management plans and reports, periodic safety updates and clinical sections of product labels.

 

This role requires the management proficiencies and leadership competencies to demonstrably lead external stakeholders through influence while simultaneously demonstrating proficiencies in scientific engagement via peer-to-peer consultations with governmental officers, physicians, payors, professional societies, patient advocacy groups, as well as health system and integrated delivery networks worldwide. The successful candidate will bring a combination of strategic mindset, strong operational involvement (“hands on mentality”), together with the personality traits of being a team player, humble and inquisitive, along with servant leadership skills.

 

In addition to supporting all Olympus IP activities, the IPL will design, develop, and deploy program level activities including authoring/reviewing infection prevention safety and efficacy summaries, clinical white papers, and scientific publications, coordinating thought leadership with outside experts, scientific societies, as well as global public health agencies, notified bodies, competent authorities, and Non-Governmental Organizations. In addition to work on IP specific activities the IPL will participate in standing committees, review post market surveillance trends, perform due diligence reviews, and consult to new business development on emerging market opportunities as well as contribute to the target product profile for new product development.

Job Duties

• Provide deep expertise, insights, as well as scientific and clinical leadership to IP strategy and strategic decision making while maintaining a sharp focus on patient safety throughout the product lifecycle, including new product development processes, R&D engineering, risk management, clinical trials, post-market safety surveillance, health hazard assessments and field corrective actions.
• Serve as the single point of contact for the US Centers of Disease Control, European Centers for Prevention & Disease Control, notified bodies, regulatory ag